HOME
BUSINESS
MARKETS
BIOTECH
LIFESTYLE
TRENDING
Search
Financial Trends
HOME
BUSINESS
MARKETS
BIOTECH
LIFESTYLE
TRENDING
Tag: Idera Pharmaceuticals Inc
Health
Idera Pharmaceuticals Inc (NASDAQ:IDRA) Update On IMO-2125
Ash Sandifer
-
Health
Idera Pharmaceuticals Inc (NASDAQ:IDRA) Reports FDA Orphan Drug Status For ‘IMO-2125’
Brandon Manns
-
Business
Idera Pharmaceuticals Inc (NASDAQ:IDRA) Appoints New Secretary To The Board
Aaron Lyons
-
Health
Idera Pharmaceuticals Inc (NASDAQ:IDRA)’s IMO-8400 Shows Positive Data from Clinical &...
Aaron Lyons
-
Health
Idera Pharmaceuticals Inc. (NASDAQ:IDRA): First Quarter Net Loss Widened To $9.1...
Aaron Lyons
-
Health
Idera Pharmaceuticals Inc (NASDAQ:IDRA) Announces Closing Of Public Offer
Neha Rathod
-
Health
Idera Pharmaceuticals Inc (NASDAQ:IDRA)’s shares rose by 15.64% in Friday’s trading
Rebecca Harrison
-
